Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 604 (MIR604)
- Target
- MIR604
- Molecular classification
- MicroRNA, Non-coding RNA, Other
01
Overview
MicroRNA 604 (MIR604) is a short, non-coding RNA molecule that is predicted to be involved in miRNA-mediated post-transcriptional gene silencing by guiding the RNA-induced silencing complex (RISC) to complementary mRNA targets, thereby repressing their expression[3][1]. Like other microRNAs, it is not a receptor or enzyme but acts as an endogenous regulator of gene expression, influencing various physiological and pathological processes. Specific biological or disease roles for MIR604 are currently limited in the literature, and it has not emerged as a principal therapeutic target or biomarker in clinical practice[3][1].
- Other names
- hsa-mir-604MIRN604MIR604hsa-miR-604
02
Mechanism of action
Not applicable. Drugs do not directly target MIR604 as a therapeutic mechanism.
03
Biological functions
Post-transcriptional gene silencingRegulation of mRNA stability and translationModulation of gene expression
04
Disease associations
Other (MicroRNAs broadly implicated in cancer, immune regulation, and developmental processes, but specific disease roles for MIR604 are not well-defined in current literature)
05
Safety considerations
None specific. Modulation of microRNAs as a class is associated with concerns of off-target effects, pleiotropic gene regulation, and difficulties in targeted delivery, but no unique issues are noted for MIR604.
06
Interacting drugs
None identified. No specific drugs are presently documented to directly interact with or target MIR604.
07
Biomarkers
None identified. MIR604 has not been specifically established as a biomarker for patient selection or efficacy monitoring.
Beyond the preview
Go deeper on MicroRNA 604 (MIR604).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MicroRNA 604 (MIR604).